Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
Biocon Biosimilar - Google News
Get the latest updates from Biocon Biosimilar - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 9 hours ago
Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules - Business Standard
10 days ago
Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules Business Standard
Biocon gets nod from SAHPRA for Tacrolimus capsules - Business Standard
12 days ago
Biocon gets nod from SAHPRA for Tacrolimus capsules Business Standard
Biocon may list biosimilars business by 2025 first half - CEO - Yahoo Lifestyle Australia
13 days ago
Biocon may list biosimilars business by 2025 first half - CEO Yahoo...
Biocon deal with Biomm for generic Ozempic - The Pharma Letter
14 days ago
Biocon deal with Biomm for generic Ozempic The Pharma Letter
Biocon And Eris Strike Indian Deal Over Branded Formulations - Generics Bulletin
14 days ago
Biocon And Eris Strike Indian Deal Over Branded Formulations Generics Bulletin
Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil - Business Standard
14 days ago
Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil...
Biocon jumps after inking pact with Biomm SA - Business Standard
14 days ago
Biocon jumps after inking pact with Biomm SA Business Standard
Mission Fulphila - Mylan-Biocon Biosimilar Neulasta Takes The Stage In US - In Vivo
15 days ago
Mission Fulphila - Mylan-Biocon Biosimilar Neulasta Takes The Stage In US In...
Biocon partners Biomm SA to commercialise it's diabetes drug in Brazil - Business Standard
15 days ago
Biocon partners Biomm SA to commercialise it's diabetes drug in Brazil Business...
Biocon partners Biomm to commercialise diabetes drug in Brazil - Zee Business
15 days ago
Biocon partners Biomm to commercialise diabetes drug in Brazil Zee Business
Intertek's Ashleigh Wake On Opportunities And Challenges With Biosimilars – An Interview With PharmAsia News - HBW Insight
16 days ago
Intertek's Ashleigh Wake On Opportunities And Challenges With Biosimilars – An Interview...
Biocon leads generic race for blockbuster weight loss drugs as patents set to expire soon - The Financial Express
25 days ago
Biocon leads generic race for blockbuster weight loss drugs as patents set...